Efficacy of Percutaneous Coronary Intervention for Acute Anterior Myocardial Infarction Patients with Two Kinds of Dosage for Atorvastatin

马蕊,王耿,韩雅玲,赵昕,刘海伟,周薇薇,李智,张莉莉
2014-01-01
Abstract:To study the efficacy of percutaneous coronary intervention for acute anterior myocardial infarction on patients with different doses statin therapy during hospitalization , a total of 140 patients with first acute anterior myocardial infarction were randomly divided into two groups .The experiment group was given 80 mg atorvastatin before PCI in combination with 40 mg atorvastatin after PCI ,until discharge .The control group was given 20 mg atorvastatin each night .Before PCI ,24h after PCI and before discharge , the levels of cardiac markers were detected . NT-pro brain natriuretic peptide (NT-proBNP ) and left ventricular ejection fraction (LVEF ) that examined by using Doppler echocardiography were detected before the operation and discharge .The incidence of major adverse cardiovascular events was recorded during the period of hospitalization .Comparing between the two groups ,the LVEF had no significant difference (P=0 .249) .During the period of hospitalization ,NT-proBNP in the control group was higher than before (P=0 .00) .Compared with the study group ,the level of NT-proBNP in the contrd group was significantly higher than that after the treatment (P=0 .02) .There were no major adverse cardiac events (MACEs) occurring during the hospitalization . Therefore ,the intensive treatment of short-term atorvastatin can reduce the value of NT-proBNP ,and can improve left ventricular function for patients with the first acute anterior myocardial infarction after directly to PCI .
What problem does this paper attempt to address?